RIGON, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.146
EU - Europa 265
AS - Asia 206
OC - Oceania 2
Totale 1.619
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.144
IT - Italia 100
CN - Cina 82
SG - Singapore 81
DE - Germania 45
SE - Svezia 45
FI - Finlandia 17
FR - Francia 17
GB - Regno Unito 16
VN - Vietnam 14
UA - Ucraina 10
IN - India 9
HK - Hong Kong 8
IE - Irlanda 5
IR - Iran 3
JP - Giappone 3
MY - Malesia 3
AU - Australia 2
ES - Italia 2
NL - Olanda 2
PT - Portogallo 2
RS - Serbia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
CA - Canada 1
ID - Indonesia 1
LA - Repubblica Popolare Democratica del Laos 1
PA - Panama 1
Totale 1.619
Salva come PNG Salva come JPEG
Città #
Fairfield 134
Chandler 118
Woodbridge 115
Ann Arbor 97
Houston 92
Ashburn 87
Cambridge 62
Singapore 62
Seattle 48
Wilmington 44
Jacksonville 35
Padova 35
Boardman 34
New York 20
San Diego 20
Santa Clara 19
Beijing 18
Des Moines 17
Princeton 17
Medford 15
Dong Ket 14
Milan 12
Düsseldorf 10
Helsinki 9
Nanjing 9
Rome 9
Frankfurt am Main 8
Munich 8
Wan Chai 8
Cagliari 6
Roxbury 6
Dublin 5
Auburn Hills 3
Hebei 3
Ipoh 3
Monza 3
Parma 3
Pune 3
Tokyo 3
Belgrade 2
Brookline 2
Changsha 2
Florence 2
Huzhou 2
London 2
Manchester 2
Moscow 2
Mumbai 2
Nanchang 2
Naples 2
Nuremberg 2
Roslindale 2
Shanghai 2
Sydney 2
Venice 2
Vicenza 2
Amsterdam 1
Aprilia 1
Buti 1
Catania 1
Chioggia 1
Chiswick 1
Chongqing 1
Delhi 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Indiana 1
Jakarta 1
Jiaxing 1
Jinan 1
Jinhua 1
Kashan 1
Kharkiv 1
Kilburn 1
Lachine 1
Lanzhou 1
Lisbon 1
Los Angeles 1
Ogden 1
Orange 1
Panama City 1
Paris 1
Phoenix 1
Pittsburgh 1
Sant'elena 1
Selvazzano Dentro 1
Shenyang 1
Tianjin 1
Vientiane 1
Washington 1
Wuhan 1
Zhengzhou 1
Totale 1.285
Salva come PNG Salva come JPEG
Nome #
Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation 163
Circadian transcriptome analysis in human fibroblasts from Hunter syndrome and impact of iduronate-2-sulfatase treatment 153
RNA-seq Transcriptome Profiling Of Primary Hunter Cells Following Treatment With Recombinant IDS As A First Step For Identification Of ERT Efficacy Markers 136
LGI1 microdeletion in autosomal dominant lateral temporal epilepsy. 115
Targeted Polymeric Nanoparticles for Brain Delivery of High Molecular Weight Molecules in Lysosomal Storage Disorders 111
Brain RNA-seq profiling of the mucopolysaccharidosis type II mouse model 109
FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII). 100
ADAM23, a Gene Related to LGI1, Is Not Linked to Autosomal Dominant Lateral Temporal Epilepsy. 99
BBB Crossing in Lysosomal Storage Disorders: A Nanoparticle-Based Approach 80
Targeting brain disease in MPSII: Preclinical evaluation of IDS-loaded PLGA nanoparticles 68
Hematopoietic Stem and Progenitor Cell Gene Therapy Uniquely Benefits Multiple Sclerosis in the Animal Model 54
Nanotechnologies for CNS drug delivery: therapy for the neurological compartment in the Mucopolisaccharidoses 54
Exploiting the potential of drosophila models in lysosomal storage disorders: Pathological mechanisms and drug discovery 53
Development of an Ex Vivo Gene Therapy for Frontotemporal Dementia (FTD) 51
Drosophila d-idua reduction mimics mucopolysaccharidosis type i disease-related phenotypes 49
Molecular diagnosis of patients affected by mucopolysaccharidosis: a multicenter study 48
Preclinical Development of an Ex Vivo Gene Therapy for Mucopolysaccharidosis Type II 39
Mucopolysaccharidosis type II: One hundred years of research, diagnosis, and treatment 32
Corrigendum: FGF signaling deregulation is associated with early developmental skeletal defects in animal models for mucopolysaccharidosis type II (MPSII) [Human Molecular Genetics, 27, 13, (2018) (2262-2275)] DOI: 10.1093/hmg/ddy131 24
A GENOMIC DELETION SPANNING PART OF LGI1 ASSOCIATED WITH AUTOSOMAL DOMINANT LATERAL TEMPORAL EPILEPSY 24
Early diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approach 22
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 21
Glycosaminoglycan signatures in body fluids of mucopolysaccharidosis type II mouse model under long-term enzyme replacement therapy 21
Modeling Mucopolysaccharidosis Type II in the Fruit Fly by Using the RNA Interference Approach 18
Totale 1.644
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.592
article - articoli 7.314
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.906
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 0 0 0 0 22 16 19 28 22 25 24 7
2020/2021205 11 9 7 13 20 14 3 15 25 43 19 26
2021/2022247 12 16 27 25 33 13 17 19 14 6 19 46
2022/2023252 26 17 4 32 34 41 1 23 29 28 13 4
2023/2024228 7 22 18 26 17 33 31 9 6 11 29 19
2024/2025207 6 67 55 41 38 0 0 0 0 0 0 0
Totale 1.644